Start the conversation
The biotech market has sold off last week, with the Nasdaq Biotechnology Index dropping 6.4% since April 23. And because of that, some of the best biotech stocks have dipped as well.
Now, investors are wondering if they should take their money to the sideline. But Money Morning's Bioscience Investing specialist Ernie Tremblay says this type of move is normal for the biotech market.